Skip to main content
. 2024 Jul 23;13(8):682. doi: 10.3390/antibiotics13080682

Figure 1.

Figure 1

Overview of the CRGNB studied from Hesse, 2016–2019. (A) Percentage distribution of carbapenemase-producing (CP) and non-carbapenemase-producing (NCP) CRGBN; (B) Year-wise species distribution of all carbapenem-resistant bacteria, CP and NCP-CRGNB; (C) Numbers of identified carbapenemase types; (D) Carbapenemase distribution according to the species. * = OXA-48-like.